Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Chemodex
Enalaprilat
Product Details | |
---|---|
Synonyms | EAL; Enalapril acid; MK-422 |
Product Type | Chemical |
Properties | |
Formula | C18H24N2O5 |
MW | 348.4 |
CAS | 76420-72-9 |
RTECS | TW3590600 |
Source/Host Chemicals | Synthetic. |
Purity Chemicals | ≥99% (HPLC) |
Appearance | White solid. |
Solubility | Slightly soluble in water. |
Identity | Determined by NMR. |
Declaration | Manufactured by Chemodex. |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
InChi Key | LZFZMUMEGBBDTC-QEJZJMRPSA-N |
Smiles | C[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice |
Keep cool and dry. Protect from light and moisture. |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Active metabolite enalapril. Nonsulfhydryl angiotensin-converting enzyme (ACE) inhibitor. Shown to improve cardiac preservation via bradykinin receptor and PKC without affecting ATP metabolism. Has some antioxidant activity, which does not include the PKC-NADPH oxidase pathway. Increases PPARβ/δ expression, without influence on PPARα and PPARγ.
(1) D.J. DiPette, et al.; Clin. Pharmacol. Ther. 38, 199 (1985) | (2) J.G. Kelly & K. O'Malley; Clin. Pharmacokinet. 19, 177 (1990) | (3) X. Yang, et al.; J. Mol. Cell Cardiol. 28, 1445 (1996) | (4) R. Lupi, et al.; Eur. J. Endocrinol. 154, 355 (2006) | (5) M. Yu, et al.; Molecules 17, 2738 (2012) | (6) H. Cernecka, et al.; Eur. J. Pharmacol. 714, 472 (2013)